Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9


Single β-lactams versus combinations as empiric therapy for infections with Pseudomonas aeruginosa: assessing the in vitro susceptibility.

Almarzoky Abuhussain SS, Sutherland CA, Nicolau DP.

Infect Dis (Lond). 2020 Jan;52(1):33-38. doi: 10.1080/23744235.2019.1673900. Epub 2019 Oct 9.


In vitro potency of antipseudomonal β-lactams against blood and respiratory isolates of P. aeruginosa collected from US hospitals.

Almarzoky Abuhussain SS, Sutherland CA, Nicolau DP.

J Thorac Dis. 2019 May;11(5):1896-1902. doi: 10.21037/jtd.2019.05.13.


Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department.

Almarzoky Abuhussain SS, Burak MA, Kohman KN, Jacknin G, Tart SB, Hobbs ALV, Adams DK, Nailor MD, Keyloun KR, Nicolau DP, Kuti JL.

BMC Health Serv Res. 2018 Dec 4;18(1):932. doi: 10.1186/s12913-018-3751-0.


In Vivo Efficacy of Humanized WCK 5222 (Cefepime-Zidebactam) Exposures against Carbapenem-Resistant Acinetobacter baumannii in the Neutropenic Thigh Model.

Almarzoky Abuhussain SS, Avery LM, Abdelraouf K, Nicolau DP.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01931-18. doi: 10.1128/AAC.01931-18. Print 2019 Jan.


Variability in Emergency Medicine Provider Decisions on Hospital Admission and Antibiotic Treatment in a Survey Study for Acute Bacterial Skin and Skin Structure Infections: Opportunities for Antimicrobial Stewardship Education.

Almarzoky Abuhussain SS, Burak MA, Adams DK, Kohman KN, Tart SB, Hobbs ALV, Jacknin G, Nailor MD, Keyloun KR, Nicolau DP, Kuti JL.

Open Forum Infect Dis. 2018 Oct 8;5(10):ofy206. doi: 10.1093/ofid/ofy206. eCollection 2018 Oct.


Optimizing skin and skin structure infection outcomes: considerations of cost of care.

Almarzoky Abuhussain SS, Goodlet KJ, Nailor MD, Nicolau DP.

Expert Rev Pharmacoecon Outcomes Res. 2018 Jun;18(3):235-244. doi: 10.1080/14737167.2018.1450142. Epub 2018 Mar 14. Review.


Efficacy of Human-Simulated Exposures of Ceftolozane-Tazobactam Alone and in Combination with Amikacin or Colistin against Multidrug-Resistant Pseudomonas aeruginosa in an In Vitro Pharmacodynamic Model.

Rico Caballero V, Almarzoky Abuhussain S, Kuti JL, Nicolau DP.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e02384-17. doi: 10.1128/AAC.02384-17. Print 2018 May.


Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.

Monogue ML, Almarzoky Abuhussain SS, Kuti JL, Nicolau DP.

Am J Health Syst Pharm. 2018 Jan 1;75(1):e36-e44. doi: 10.2146/ajhp170123. Erratum in: Am J Health Syst Pharm. 2018 Dec 1;75(23):1848.


Supplemental Content

Loading ...
Support Center